# FDA Inspection 1162839 - Guillaume M. Canaud, MD, PhD - February 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/guillaume-m-canaud-md-phd/0390f5b0-b02b-493d-890c-75e9be3f7285
Source feed: FDA_Inspections

> FDA Inspection 1162839 for Guillaume M. Canaud, MD, PhD on February 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162839
- Company Name: Guillaume M. Canaud, MD, PhD
- Inspection Date: 2022-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/guillaume-m-canaud-md-phd/5cbf31d7-aa02-4dd9-8d67-445d93b84284

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c